102 reports of this reaction
3.0% of all NITROUS OXIDE reports
#5 most reported adverse reaction
BRADYCARDIA is the #5 most commonly reported adverse reaction for NITROUS OXIDE, manufactured by AGL Welding Supply Co., Inc.. There are 102 FDA adverse event reports linking NITROUS OXIDE to BRADYCARDIA. This represents approximately 3.0% of all 3,365 adverse event reports for this drug.
Patients taking NITROUS OXIDE who experience bradycardia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BRADYCARDIA is a less commonly reported adverse event for NITROUS OXIDE, but still significant enough to appear in the safety profile.
In addition to bradycardia, the following adverse reactions have been reported for NITROUS OXIDE:
The following drugs have also been linked to bradycardia in FDA adverse event reports:
BRADYCARDIA has been reported as an adverse event in 102 FDA reports for NITROUS OXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
BRADYCARDIA accounts for approximately 3.0% of all adverse event reports for NITROUS OXIDE, making it a notable side effect.
If you experience bradycardia while taking NITROUS OXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.